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Optimizing Identification of Clinically Relevant Gram-Positive
Organisms by Use of the Bruker Biotyper Matrix-Assisted Laser
Desorption Ionization–Time of Flight Mass Spectrometry System
Erin McElvania TeKippe,a Sunni Shuey,b David W. Winkler,b Meghan A. Butler,b Carey-Ann D. Burnhama
Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, Missouri, USAa; St. Louis Children’s Hospital, St. Louis, Missouri, USAb
Matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS) can be used as a method for the
rapid identification of microorganisms. This study evaluated the Bruker Biotyper (MALDI-TOF MS) system for the identifica-
tion of clinically relevant Gram-positive organisms. We tested 239 aerobic Gram-positive organisms isolated from clinical speci-
mens. We evaluated 4 direct-smear methods, including “heavy” (H) and “light” (L) smears, with and without a 1-l direct for-
mic acid (FA) overlay. The quality measure assigned to a MALDI-TOF MS identification is a numerical value or “score.” We
found that a heavy smear with a formic acid overlay (HFA) produced optimal MALDI-TOF MS identification scores and the
highest percentage of correctly identified organisms. Using a score of>2.0, we identified 183 of the 239 isolates (76.6%) to
the genus level, and of the 181 isolates resolved to the species level, 141 isolates (77.9%) were correctly identified. To maximize
the number of correct identifications while minimizing misidentifications, the data were analyzed using a score of>1.7 for
genus- and species-level identification. Using this score, 220 of the 239 isolates (92.1%) were identified to the genus level, and of
the 181 isolates resolved to the species level, 167 isolates (92.2%) could be assigned an accurate species identification. We also
evaluated a subset of isolates for preanalytic factors that might influence MALDI-TOF MS identification. Frequent subcultures
increased the number of unidentified isolates. Incubation temperatures and subcultures of the media did not alter the rate of
identification. These data define the ideal bacterial preparation, identification score, and medium conditions for optimal identi-
fication of Gram-positive bacteria by use of MALDI-TOF MS.
Phenotypic methods for the identification of bacteria in theclinical laboratory vary by laboratory and often include sub-
jective test interpretation. An alternative method for bacterial
identification that is emerging in clinical microbiology is matrix-
assisted laser desorption ionization–time of flight mass spectrom-
etry (MALDI-TOFMS).MALDI-TOFMS has been described as a
rapid, cost-effective, and reliable method for the identification of
bacteria in the clinical laboratory (1, 2, 3, 4, 5, 6, 7, 8, 9). During
MALDI-TOF MS identification, a spectral profile representing a
“fingerprint” of bacterial proteins is generated. The spectrumgen-
erated from a particular isolate can be compared to that of a ref-
erence database for organism identification. Ribosomal proteins
are primarily used for identification due to their relative abun-
dance in the bacterial cell (10).
Many studies have been published that demonstrate the utility
of MALDI-TOF MS for the identification of specific groups of
Gram-positive bacteria, including Staphylococcus aureus, coagu-
lase-negative staphylococci, Streptococcus agalactiae, viridans
group streptococci, atypical catalase-negative Gram-positive
cocci, Listeria spp., and Corynebacterium spp. (11, 12, 13, 14, 15,
16, 17, 18). These publications have focused on two methods by
which bacterial isolates can be prepared for MALDI-TOF MS
analysis. The first is the direct application of a thin filmor smear of
bacteria onto the stainless steel target from an isolated colony,
which is a rapid-identification method. Due to the thick pepti-
doglycan cell walls of Gram-positive bacteria, this method of
preparation can sometimes result in poor MALDI-TOFMS spec-
tra (6). To achieve better spectra, a protein extraction may be
performed (1, 6). This process can be relatively time- and labor-
intensive and can be disruptive to the workflow of the clinical
laboratory. We sought to optimize the sample preparation pro-
cess, from both accuracy and workflow standpoints. We evaluated a
methodofbacterial preparation that is an intermediatebetween these
two well-described methods, a 1-l formic acid overlay applied di-
rectly over the dried organism on the stainless steel target (19).
The objective of this study was to evaluate the ability of
MALDI-TOFMS to accurately identify clinically relevant aerobic
Gram-positive bacteria using a formic acid overlay method, and
we focused on the optimization of methods to achieve the highest
rate of identification without introducing misidentifications. In
addition, this study evaluates the impact of different incubation
temperatures, media types, and subculture frequency to deter-
mine if these conditions impact MALDI-TOF MS identification.
An accompanying paper by Ford and Burnham (20) aims to val-
idate the Bruker Biotyper system for clinical use for identification
of Gram-negative bacteria.
(This work was presented in part at the 112thGeneralMeeting of
the American Society for Microbiology, San Francisco, CA, June
2012.)
MATERIALS AND METHODS
Bacterial isolates. Two hundred thirty-nine aerobic Gram-positive or-
ganisms isolated from clinical specimens were included in this study. This
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collection was comprised of Streptococcus spp. (n  81), Staphylococcus
spp. (n 69), Enterococcus spp. (n 24), Bacillus spp. (n 12), Coryne-
bacterium spp. (n 20), miscellaneous Gram-positive rods (n 23), and
miscellaneous Gram-positive cocci (n  10) (Table 1). Of these isolates,
222 (93%) were fresh isolates recovered from clinical specimens at St.
Louis Children’s Hospital between June andNovember 2011, and 17were
from frozen stocks (Table 2). Isolates were tested for growth on blood
(n 229), chocolate (n 5), and colistin and nalidixic acid (CNA) agars
(n  5). Phenotypic identification of isolates was performed using con-
ventional biochemical testing per the standard operating procedures for
that organism type in the laboratory. 16S rRNA gene sequencing and
additional biochemical testing were performed as required for discrepant
resolution (21, 22, 23, 24). 16S rRNA gene sequencing was performed in
our laboratory as described previously (23). All analyses in this study were
performed to the same level of resolution used for the clinical reporting of
these isolates.
Validation study design. To validate MALDI-TOF MS for use with
Gram-positive bacteria in our laboratory, we planned to test at least 200
isolates, representing aminimumof 15 species, but using nomore than 35
isolates of a single species. The isolates were to represent the regular flow
of organisms in the clinical lab, with the supplementation of organisms
rarely seen in the laboratory. All isolates were tested in quadruplicate as
detailed below. Isolates that did not obtain an acceptable score (2.0)
were reanalyzed, and if an acceptable score was not obtained a second
time, the isolate was analyzed by MALDI-TOF MS following formic acid
extraction.
Preparation of bacteria for MALDI-TOF MS analysis. To evaluate
sample preparations, 4 direct-smear (DS) methods were performed. Us-
ing a toothpick, a very thin layer of bacteria from a single colony was
applied to the stainless steel target (“heavy” smear [H]). Then, using the
same toothpick, bacteria were applied to an adjacent spot on the target
without returning to the plate for additional bacteria (“light” smear [L]).
Heavy and light direct smears were repeated with the addition of a formic
acid overlay (HFA and LFA, respectively), consisting of 1 l of 100%
formic acid placed directly on top of the dried organism on the stainless
steel target. The formic acid overlay was left to air dry and, subsequently,
1 l of matrix (-cyano-4-hydroxycinnamic acid) (part no. 255344,
BrukerDaltonics, Inc., Billerica,MA)was added to each spot on the target
and left to dry at room temperature (RT).
MALDI-TOF mass spectrometry. Spectra were generated and ana-
lyzed using the MALDI Biotyper flexControl operating system and the
Bruker Biotyper 3.0 system software and taxonomy library. MALDI-TOF
MS analysis was performed in automatic mode, and a minimum of 240
laser shots were collected for each isolate. Bacterial test standard (BTS)
(part no. 255343, Bruker Daltonics, Inc.) was used on each run as a cali-
brator and for quality control.
Formic acid extraction. A single large colony or 2 to 3 small colonies
of bacteria underwent formic acid extraction as described previously (1).
Onemicroliter of the extract was spotted onto theMALDI-TOFMS stain-
less steel target and left to air dry, after which 1 l of matrix was added to
each direct bacterial smear and left to air dry before commencingMALDI-
TOF MS analysis in automatic mode.
Media studies. A subset of 28 common isolates from the study was ana-
lyzed under different growth conditions to determine if preanalytic factors
impactMALDI-TOFMS identification.The 28 isolates includedBacillus spp.
(n  2), coagulase-negative Staphylococcus spp. (n  1), Corynebacterium
spp. (n  2), Enterococcus faecalis (n  1), Enterococcus faecium (n  2),
Enterococcus spp. (n 1), groupAbeta-hemolytic Streptococcus spp. (n 3),
group B beta-hemolytic Streptococcus spp. (n 3), group G beta-hemolytic
TABLE 1 Organisms tested in this study






















Group A alpha-hemolytic Streptococcus spp. 30
Group B alpha-hemolytic Streptococcus spp. 20
Group C alpha-hemolytic Streptococcus spp. 1
















Streptococcus bovis group 2




Viridans group Streptococcus spp. 13
TABLE 2 Summary of isolates, extent of analysis, and primary media
from which isolates were tested
Category
No. of isolates (of a total







Direct smear 219 91.6
Repeat direct smear 20 8.4
Full extraction 7 2.9
16S rRNA gene sequencing 17 7.1
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Streptococcus spp. (n 1), S. aureus (n 3), Staphylococcus epidermidis (n
2), Streptococcus mitis group (n 2), Streptococcus pneumoniae (n 3), and
viridans group Streptococcus spp. (n  2). Isolates were analyzed following
incubation for 5days at various temperatures (35°C, 4°C, andRT), growthon
various media (blood agar plate [BAP], chocolate agar, and CNA agar), and
following daily subculture (1, 3, 4, and 5 days) prior to MALDI-TOF MS
identification.
Statistical analysis.GraphPadPrism5 softwarewas used for statistical
analysis. Analysis of variance (ANOVA), chi-square, and Fisher’s exact
tests were used to determine significance. A P value of 0.05was considered
statistically significant.
RESULTS
Modified formic acid overlay enhances MALDI-TOF identifica-
tion. We performed four spotting techniques to determine which
would provide the highest overall MALDI-TOF score for identifi-
cation of the most clinical isolates. After analyzing all four direct-
smearmethods, we found that HFA achieved the highest overall
mean MALDI-TOF MS score (Table 3), which was statistically
significant compared to all other spotting methods (P 0.0001).
HFA also resulted in the highest number of correctly identified
organisms (Table 4). Using the HFA method and a cutoff of
2.0 for genus- and species-level identification, we identified 183
of the 239 isolates (76.6%) to the genus level, and of those pheno-
typically identified to the species level, we correctly identified 141
of the 181 isolates (77.9%). This was a 20% enhancement in iden-
tification to the genus level (P  0.0001) and a 17% increase in
species-level identification compared to heavy inoculation with-
out the formic acid overlay (P  0.0006). The use of formic acid
was especially beneficial for the identification of Streptococcus spp.
(P 0.0002 for genus-level and P 0.0004 for species-level iden-
tification) but did not significantly increase the number of Staph-
ylococcus spp. identified.Other organism groupswere not individ-
ually analyzed due to the low number of isolates in each group.
Using a score of 2.0, all isolates were correctly identified to the
genus level, and one isolate, S. mitis (1.3%), was misidentified by
MALDI-TOF at the species level. These data show that the addi-
tion of a formic acid overlay enhanced Gram-positive bacterial
identification by MALDI-TOF MS by improving the MS output
score and resulted in identifying more isolates.
MALDI-TOF identification scores. The Bruker Biotyper ex-
presses the identification of an organism as a “score” based on
pattern matching. Rather than relying on the scoring scheme rec-
ommended by the manufacturer, we evaluated cutoffs between
2.0 and 1.7 for genus- and species-level identification. We
optimized the reporting of Gram-positive bacteria based on this
score such that we maximized the rate of correct identifications
and minimized the number of incorrect identifications. In our
data set, all isolates but one with a score of 2.0 were correctly
identified by MALDI-TOF MS (S. mitis group). We analyzed our
data by reducing the score for acceptable genus- and species-level
identification by increments of 0.1, using scores ranging from
2.0 to1.7 to determine howmany additional isolates would be
correctly identified and misidentified at each score. Using a score
of1.7, we identified 220 of the 239 isolates (92.1%) to the genus
level, and of the 181 isolates requiring species-level identification
per standard operating procedures, 167 isolates (92.2%)were cor-
rectly identified (Table 4). This is a 15.5% increase in genus-level
identification (P  0.0001) and a 14.3% increase in species-level
identification compared to using a2.0 cutoff score (P 0.0001).
Reducing the score from2.0 to1.7was especially helpful in the
identification of Staphylococcus spp. (P  0.0047 for genus-level
and P  0.0080 for species-level identification) but less so for
Streptococcus spp., where only a modest increase in identification
was achieved. Other organism groups were not analyzed due to
the low numbers of isolates in each group. Reducing the accept-
able score to 1.7 resulted in only one additional misidentified
isolate, a second isolate of the S. mitis group. These data show the
importance of optimizing the acceptable MALDI-TOFMS confi-
dence score for each organism group.
Unidentified and discrepant organisms. Six isolates were not
identified by MALDI-TOF MS: Dolosigranulum pigrum, Saccha-
rothrix sp., Corynebacterium sp., Granulicatella sp., and two Strepto-
myces spp. isolates. All genera except Dolosigranulum are present in
the Bruker Biotyper MS 3.0 system database. It has been demon-
stratedpreviously thatmodified extraction techniques are needed for
optimal MALDI-TOFMS identifications for aerobic actinomycetes;
these techniques were not performed in this study andmight explain
why our Streptomyces isolates were not identified (25).
Of the 239 organisms tested, 19 isolates had discrepant results
between the phenotypic and MALDI-TOF MS organism iden-
tifications (Table 5). 16S rRNA gene sequencing and additional
biochemical testing showed that MALDI-TOF MS correctly
identified 17 of the 19 discrepant isolates. Two isolates were
phenotypically identified as S. mitis group by Gram stain, colony
morphology, bile solubility testing, optochin susceptibility
testing, and Vitek 2 automated identification system but were
identified as S. pneumoniae by MALDI-TOF MS with high confi-
dence scores (1.915 and 2.001). Problems with discriminating be-
TABLE 3 Mean score and standard deviation of MALDI-TOF MS analysis of Gram-positive isolates using four direct-smear methods
Organism No. of isolates
Direct-smear typea
Heavy Light HFA LFA
Overall 239 2.096 (0.188) 2.124 (0.186) 2.204 (0.193)b 2.110 (0.269)
Streptococcus spp. 81 2.100 (0.200) 2.150 (0.164) 2.234 (0.180) 2.100 (0.194)
Staphylococcus spp. 69 2.104 (0.138) 2.111 (0.142) 2.195 (0.173) 2.107 (0.187)
Enterococcus spp. 24 2.131 (0.272) 2.177 (0.313) 2.303 (0.228) 2.254 (0.263)
Bacillus spp. 12 2.015 (0.080) 1.990 (0.159) 2.056 (0.204) 2.019 (0.320)
Corynebacterium spp. 20 2.137 (0.212) 2.167 (0.191) 2.217 (0.200) 2.202 (0.213)
Miscellaneous Gram-positive rods 23 1.980 (0.164) 2.020 (0.166) 2.084 (0.169) 1.953 (0.216)
Miscellaneous Gram-positive cocci 10 2.037 (0.166) 2.117 (0.134) 2.135 (0.205) 2.091 (0.217)
a Data are presented as the means SD.
b HFA achieved the highest overall score, which was statistically higher than all other direct-smear methods (P 0.0001).
Gram-Positive Identiﬁcation Using MALDI-TOF MS
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tween S. pneumoniae and S. mitis group organisms by MALDI-
TOF MS have been reported previously (5, 6, 7, 9, 16).
Based on reporting in the clinical laboratory, our study in-
cluded nine isolates phenotypically identified as S. pneumoniae,
two as S. mitis group, and 13 as viridans group Streptococcus
(VGS). All nine isolates phenotypically identified as S. pneu-
moniaewere also identified as S. pneumoniae byMALDI-TOFMS.
Of the two isolates identified as S. mitis by phenotypic methods
and as S. pneumoniae by MALDI-TOF MS, repeat biochemical
testing showed these two isolates to be optochin resistant and bile
solubility test negative, which is consistent with S. mitis group.
Thirteen isolates in our study were identified and reported as VGS
in our clinical laboratory. All of these isolates were optochin resis-
tant and were not bile soluble, and five of the 13 isolates were incor-
rectly identified as S. pneumoniae by MALDI-TOF MS. These data
highlight thenecessityof confirmingall isolates thatwere identifiedas
S. pneumoniaebyMALDI-TOFMSwith additionalmethods, such as
an optochin disk and/or a bile solubility test.
Full extraction for identification of Gram-positive isolates.
Of the 239 isolates tested in this study, 20 isolates did not initially
generate a score of 1.7 using any DS method (Table 2). Repeat
MALDI-TOF MS testing was performed on 17 of the isolates (3
isolates could not be recovered for repeat analysis). Ten of the 17
isolates (58.8%) were successfully identified upon repeatMALDI-
TOF MS using a score of 1.7. A full formic acid extraction was
performed on 7 of the isolates with a score of 1.7 on repeat
analysis. Only one of the seven isolates was identified by MALDI-
TOF MS following full extraction (14.3%; 0.4% of all isolates in
the study). These data suggest that full extraction is unlikely to be
useful for Gram-positive organisms that are not identified using
the 1-l formic acid overlay method. If an organism is unidenti-
fied after repeat MALDI-TOF MS testing, phenotypic testing or
sequence-based identification should be considered.
Media studies. A subset of 28 common isolates was analyzed
after 5 days of incubation at 4°C, room temperature (RT), and
35°C (Fig. 1A). The number of correctly identified isolates was
calculated using decreasing cutoff vales of2.0,1.9,1.8, and
1.7 for acceptable genus- and species-level identification. The
average MALDI-TOF scores for isolates identified at 35°C, RT,
and 4°Cwere not significantly different fromone another at 2.206,
2.254, and 2.231, respectively (P 0.7505). Of interest, 4°C incu-
bation gave the best results, correctly identifying 92.9% of isolates
to the genus and species level using a cutoff score of 1.7. Incu-
bation of organisms at RT and 35°C also produced good identifi-
cation results; a score of 1.7 resulted in 82.1% and 85.7% of
isolates being identified, respectively. No isolates were misidenti-
fied at any incubation temperature.
The same subset of 28 isolates was analyzed after growth on
BAP, chocolate, and CNA agar plates (Fig. 1B). The average
MALDI-TOF scores for isolates identified from BAP, chocolate,
and CNA agars were not significantly different from one another
at 2.282, 2.234, and 2.232, respectively (P  0.5224). A score of
1.7 resulted in 100% of isolates being identified from CNA,
92.9% from BAP, and 89.3% identified from chocolate agar. No
isolates were misidentified from any medium type.
These 28 isolates were then analyzed following daily subculture
for 1, 3, 4, and 5 days to assay the impact of subculture frequency
on MALDI-TOF MS identification (Fig. 1C). The average
MALDI-TOF scores for the correct identification of isolates sub-
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2.226, 2.229, 2.227, and 2.177, respectively (P  0.9930). Al-
though the scores of correctly identified isolates were nearly iden-
tical, the identification of bacterial isolates by MALDI-TOF MS
decreased as subculture frequency increased. A score of 1.7 re-
sulted in 100%of isolates being identified on day one, which fell to
78.6% after 5 days of subculture, a 21.4% decrease. This result is
reflected in the coefficient of variation (CV), which rose from 9.1%
on day one (scores ranging from 1.737 to 2.552) to 53.7%by day five
of subculture (scores ranging from 0 to 2.480). Despite fewer isolates
being identified following repeated subculture, there were no mis-
identifications when scores of1.7 were obtained.
DISCUSSION
MALDI-TOFMS is a rapid and cost-effective way to identify bac-
teria in the clinical laboratory (2, 5, 8, 9, 26). This study evaluated
a number of preanalytic and postanalytic factors that affect
MALDI-TOF MS identification of Gram-positive bacteria to val-
idate and optimize this method for use in the clinical laboratory.
In an attempt to enrich the quality of spectra produced by
MALDI-TOF MS, we used a 1-l formic acid overlay. This im-
proved genus- and species-level identification of isolates by 20%
(P 0.0001 and P 0.0006, respectively). Our data allowed us to
reduce the score for acceptable identification to genus and species
level from2.0 to1.7 for this group of organisms, resulting in
an additional 15.5% of isolates identified to the genus level and
14.3%of isolates identified to the species level. These data indicate
that MALDI-TOF MS is a very effective way to identify Gram-
positive bacteria in the clinical laboratory.
In this study, we evaluated the protocolmodification of a direct
1-l formic acid overlay onMALDI-TOFMS identification. Sim-
ilar methods of rapid protein extraction have been reported in
studies evaluating Gram-positive and Gram-negative organisms,
as well as yeast (19, 27, 28). In all instances, the direct application
of formic acid led to an overall increase in bacterial identification
compared to direct spotting of bacteria without a formic acid
overlay. In the past, formic acid extraction of bacterial isolates was
used to improve MALDI-TOF MS spectra. This method is rela-
tively labor-intensive and does not fit well into theworkflowof the
clinical laboratory. In contrast, a 1-l formic acid overlay is easily
adaptable to the clinical workflow. Bacteria are spotted on the
stainless steel target as technologists read their cultures in real
time. At set points throughout the day or when a target is full, the
microbiology technologists add a 1-l formic acid overlay to each
spot of dried organism on the target. After a short drying period,
matrix is added to each spot. In our hands, the addition of a 1-l
formic acid overlay adds only 5 to 10 min to the MALDI-TOF
procedure, minimally impacts workflow, and improves the iden-
tification of Gram-positive bacteria by approximately 20%. With
regard to the increased diagnostic yield of performing a full formic
acid extraction, studies have shown mixed results (19, 27, 28). In
our hands, full formic acid extraction resulted in an identification
in only 1 of the 7 isolates not identified byMALDI-TOFMS using
our DS methods. Due to the minimal diagnostic gains, we do not
routinely perform formic acid extraction in our laboratory.
Reducing the acceptable score for genus- and species-level
TABLE 5 Discrepant results with MALDI-TOF MS compared to phenotypic identificationa
Phenotypic IDb MALDI-TOF ID
MALDI-TOF
scorec Methods for resolution/final IDd
Streptococcus mitis group Streptococcus pneumoniae 1.915 Phenotypic: BS, P disk, Vitek
Streptococcus mitis group Streptococcus pneumoniae 2.001 Phenotypic: BS, P disk, Vitek
Staphylococcus aureus Staphylococcus intermedius 2.2 Phenotypic: PYR
Micrococcus sp. (Vitek) Rhodococcus equi 2.269 16S rRNA gene sequencing: Rhodococcus equi
Sphingomonas paucimobilis (GS, Vitek) Cellulosimicrobium cellulans 2.221 16S rRNA gene sequencing: Cellulosimicrobium
cellulans/funkei
No ID (GS, motility, catalase, and colony morphology) Paenibacillus amylolyticus 1.754 16S rRNA gene sequencing: Paenibacillus sp.
No ID (GS, catalase, and colony morphology) Rothia aeria 2.063 16S rRNA gene sequencing: Rothia sp.
Sphingomonas paucimobilis (GS, Vitek) Arthrobacter oxydans 2.16 16S rRNA gene sequencing: Arthrobacter sp.
No ID (Vitek, Phoenix NaCl, ESC, VP) Streptococcus equinus 2.095 16S rRNA gene sequencing: Streptococcus bovis group
Streptococcus bovis group (Vitek, Phoenix, growth in
6.5% sodium chloride broth, ESC, VP)
Streptococcus equinus 2.056 16S rRNA gene sequencing: Streptococcus bovis group
Corynebacterium sp. (GS, catalase) Actinomyces neuii 2.06 16S rRNA gene sequencing: Actinomyces sp.
VGS (Vitek, Phoenix) Streptococcus parasanguinis 2.263 16S rRNA gene sequencing: Streptococcus
parasanguinis/mitis/oralis
VGS (Phoenix) Streptococcus parasanguinis 1.841 16S rRNA gene sequencing: Streptococcus
parasanguinis/mitis/oralis
Coryneform bacteria (GS) Cellulosimicrobium cellulans 2.042 16S rRNA gene sequencing: Cellulosimicrobium
cellulans
Sphingomonas paucimobilis (GS, Vitek) Cellulosimicrobium cellulans 2.164 16S rRNA gene sequencing: Cellulosimicrobium
cellulurum/funkei
Group B beta-hemolytic Streptococcus spp. (GS,
catalase, colony morphology, latex)
Streptococcus dysgalactiae 2.02 Repeat latex agglutination was positive for group G
Corynebacterium spp. (GS, CAT, Vitek, ESC, urea) Rothia dentocariosa 2.242 16S rRNA gene sequencing: Rothia dentocariosa
Leuconostoc sp./Aerococcus viridans (Vitek/Phoenix) Leuconostoc lactis 1.899 16S rRNA gene sequencing: Leuconostoc lactis
Coryneform bacteria (GS, catalase) Actinomyces radingae 1.976 16S rRNA gene sequencing: Actinomyces sp.
a The correct identifications are in bold type.
b ID, identification.
c All isolates were identified by MALDI-TOF MS using the DSFA method of bacterial preparation.
d BS, bile solubility; P disk, optochin disk; GS, Gram stain; ESC, esculin; PYR, pyrolidonyl arylamidase.
Gram-Positive Identiﬁcation Using MALDI-TOF MS
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identification from 2.0 to 1.7 resulted in a 15.5% and 14.3%
increase in genus- and species-level identification, respectively,
while introducing only onemisidentified isolate. This is similar to
other published reports in which reducing the acceptable score for
genus- and species-level identification for Gram-positive and
Gram-negative bacteria and yeast resulted in increased identifica-
tion of organisms while introducing very few misidentifications
(27, 28, 29).
Our study was designed to reflect both the common and infre-
quent isolates seen in the clinical laboratory. Unusual isolates are
more likely to be misidentified or unidentified using automated sys-
tems (13, 30, 31). MALDI-TOF MS has the potential to drastically
streamline the identificationof theseorganismsand is limitedonlyby
the completeness of the database which is used for identification. In
this study, 82.6% of miscellaneous Gram-positive rods and 90% of
miscellaneous Gram-positive cocci were identified (using a score of
1.7) with no misidentified isolates. These data indicate that
MALDI-TOFMS identification is useful for the identification of in-
frequently encountered Gram-positive organisms.
Historically, Gram-positive bacteria have not been identified
to the species level as frequently as Gram-negative organisms re-
covered from clinical specimens. Use of MALDI-TOF MS in the
clinical laboratory will provide species-level identification in
many situations where genus-level identificationwould have been
reported in the past, such as for isolates of Bacillus andCorynebac-
terium. Additionally, organisms, such as the Cellulosimicrobium
cellulans bacteria identified during this validation study, might be
identified to the genus and species level while in the past they
would have been identified only as Corynebacterium spp. or “co-
ryneform bacteria.” This increased species-level resolution might
allow us to learn more about the clinical significance of specific
taxa within these genera and might inform the pathogenic poten-
tials of certain taxa that were previously unappreciated.
One of the benefits of MALDI-TOF MS analysis is that it does
not rely on any upstream information for bacterial identification,
and missteps occurring early on in the identification process do
not impede accurate identification. This is different from auto-
mated identification systems, such as Vitek 2, which rely on the
correct interpretation of a Gram stain to determine which identi-
fication method or panel should be used for organism identifica-
tion. In our study, an isolate of Cellulosimicrobium cellulans was
incorrectly interpreted as Gram-negative bacilli on Gram stain.
This led to the use of a Vitek 2 Gram-negative card and resulted in
a misidentification of Sphingomonas (Table 5). MALDI-TOF MS
identification does not rely on interpretation of the Gram stain,
which eliminates this type of error.
Aknown limitationofMALDI-TOFMSidentification is its ability
to accurately identify S. pneumoniae from S. mitis group organisms
(5, 6, 7, 9, 16). Although they are genetically very similar, accurate
identification of these isolates to the species level is clinically impor-
tant. In keeping with previous studies, two of our isolates were iden-
tified phenotypically as non-S. pneumoniae members of the S. mitis
group but were incorrectly identified as S. pneumoniae by MALDI-
TOFMS. In our study, no S. pneumoniae isolates were assigned to a
less-pathogenic species, but 5 of the 13 VGS in our study were incor-
rectly identified as S. pneumoniae using MALDI-TOF. Therefore,
supplemental methods, such as bile solubility and/or optochin disk
susceptibility, should be considered prior to reporting an isolate as S.
pneumoniae. MALDI-TOF MS analysis cannot be used as a sole
means of identification for these organisms.
We investigated several commonly encountered preanalytical
factors and found that incubation at 35°C, RT, or 4°C or growing
isolates on blood, chocolate, or CNA agars did not have a negative
impact on MALDI-TOF MS identification. In a previous study,
Anderson et al. (32) found that MALDI-TOF MS identification
was slightly inferior if organisms were grown on CNA agar com-
pared to blood agar. That study tested a collection of 20 staphylo-
cocci, while our study assayed a more diverse group of 28 Gram-
positive organisms, which might account for the differences
observed. Interestingly, we found that increasing subculture fre-
quency had an inverse relationship with the likelihood of identi-
fication byMALDI-TOFMS. Therefore, it is suggested thatGram-
positive bacterial isolates be tested following minimal subculture
whenever possible.
In conclusion, MALDI-TOFMS was very effective in identify-
ing Gram-positive bacteria found in the clinical laboratory, in-
cluding infrequently isolated organisms. To correctly identify the
highest number of Gram-positive organisms, we recommend us-
ing a 1-l formic acid overlay, reducing the cutoff score for iden-
tification from2.0 to1.7, and using fresh isolates forMALDI-
TOF MS whenever possible.
FIG 1 Impact of preanalytical factors onMALDI-TOFMS identification. Shown
are the results ofMALDI-TOFMSanalysis of 28 common isolates after incubation
at different temperatures (A), growth on different types of media (B), and daily
subculture for up to 5 days (C). The number of correctly identified isolates was
calculated using decreasing cutoff values between2.0 and1.7 for acceptable
genus- and species-level identification. There were no statistical differences be-
tween isolates identified at different temperatures or off different media.
McElvania TeKippe et al.
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